Table 3.

Biomarker studies in humans with kidney disease using miRNAs.

MiRNA	Function	Reference
miR-101-3p, miR-127-3p, miR-210-3p, miR-126-3p, miR-26b-5p, miR-29a-3p, miR-146a-5p, miR-27a-3p, miR-93-3p, miR-10a-5p	Biomarker of AKI	Tapparo et al., 2019
miR-210 and -320	Biomarker of AKI, predictor of mortality	Chen et al., 2016
miR-21, miR-499	Biomarker of End-stage renal disease	Song et al., 2018
miR-21	Prediction of AKI development after completion of cardiac surgery	Zhang and Shu, 2016
miR-494	Biomarker of AKI in urinary specimens	Wang et al., 2017
MiR-24	Biomarker of ischemic AKI	Wilflingseder et al., 2017
miR-126 and miR-296	Vesicles derived from endothelial cells containing miR-126 and miR-296 as biomarkers of AKI	Shen et al., 2018
Mir-30c-5p and -192-5p	Urinary levels of these two miRNAs are elevated in AKI patients within 2h after admission to an ICU.	Zou et al., 2017
MiR-107	MiR-107 is induced in circulating endothelial cells (CEC) of septic AKI patients.	Wang et al., 2017